SEBELA PHARMACEUTICALS

EUIPO EUIPO 2018 Trademark registered

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The Union trademark SEBELA PHARMACEUTICALS was filed as Word mark on 11/20/2018 at the European Union Intellectual Property Office.
It was registered as a trademark on 04/15/2019. The current status of the mark is "Trademark registered".

Trademark Details Last update: October 6, 2022

Trademark form Word mark
File reference 017988320
Application date November 20, 2018
Publication date January 4, 2019
Entry date April 15, 2019
Expiration date November 20, 2028

Trademark owner

3rd Floor, West Wing, Adelaide Chambers, Peter Street
8 Dublin
IE

Trademark representatives

Prannerstraße 10 80333 München DE

goods and services

5 Pharmaceutical and medicated preparations, namely, for use in gastroenterology, rheumatology, and for use in the treatment of psychiatric disorders; pharmaceutical and medicated preparations, namely, for use in nephrology, neurology, oncology, urology, andrology and cardiology, and for use in the treatment of nasal allergies, respiratory allergies, pain and inflammation, and for use as anti-infectives; pharmaceutical preparations and substances directed to women's health for use in the treatment, alleviation and prevention of thermoregulatory dysfunctions and vasomotor symptoms including hot flashes, hot flushes, night awakenings, night sweats, and such disorders and conditions associated with perimenopause, menopause and hormonal deficiencies; menstrual symptom treatment preparations; contraceptive preparations and devices; dietary and nutritional supplements; prenatal vitamins; pharmaceutical products for the treatment of bone diseases; preparations for the suppression of hormones; pharmaceutical preparations and substances directed to women's health for use in the treatment, alleviation and prevention of overactive bladder, female sexual dysfunction, infertility, endometriosis, vaginitis, osteoporosis/osteopenia, pelvic pain, dyspareunia, and candidiasis, all the aforementioned products being not related to pharmaceuticals and medical preparations in the field of dermatology

Trademark history

Date Document number Area Entry
October 5, 2022 Change Representative, Published
November 16, 2021 Change Representative, Published
December 13, 2019 Change Representative, Published
October 25, 2019 Transfer / Change of address, Published

ID: 11017988320